INTRODUCTION
Neurofibromatosis type 1 (NF1) is a common autosomaldominant inherited disease that affects one in 3,500 people worldwide. The hallmark of this disease is the development of neurofibromas-heterogeneous, benign tumors composed of a mixture of Schwann cells (SCs), axons, ''perineurial-like'' cells, inflammatory cells, and vascular cells embedded in a rich extracellular matrix. Neurofibromas can be classified as dermal (arising exclusively in the skin) or plexiform (developing along the nerve plexus). Although dermal and plexiform neurofibromas are similar at the cellular and ultrastructural levels, only the latter can progress to the highly malignant tumors known as malignant peripheral nerve sheath tumors (MPNSTs) (Ferner, 2007; Riccardi, 1992) . Despite their mixed-cell composition, neurofibromas have been shown to originate from SCs (the main type of glia in the peripheral nervous system [PNS] ) that have undergone biallelic loss of NF1. NF1 codes for neurofibromin, a Ras-GTPase activating protein (Ras-GAP) that negatively regulates Ras signaling by accelerating the conversion of active Ras-GTP to inactive Ras-GDP (Martin et al., 1990; Xu et al., 1990) . Loss of neurofibromin leads to hyperactivation of Ras and its downstream effectors, and accordingly, elevated levels of Ras signaling are detected in NF1 À/À SCs isolated from neurofibromas or MPNSTs and have been shown to be critical for the maintenance of a transformed phenotype (Basu et al., 1992; DeClue et al., 1992; Kim et al., 1997) . In the adult, SCs exist in one of two highly quiescent, specialized states: myelinating SCs (mSCs), which myelinate larger axons, or non-mSCs, which bundle together groups of smaller axons in structures known as Remak bundles (Jessen and Mirsky, 2005) . There is no identified stem cell population in the nerve to produce new cells; instead, differentiated SCs have the capacity to dedifferentiate to a progenitor-like state. This plasticity of SCs is critical for the ability of the PNS to regenerate. Traumatic injury to the PNS produces acute tissue damage at the lesion site. Distal to the wound site, the nerve stump undergoes a series of well-characterized molecular and cellular events known as Wallerian degeneration (WD). During WD, axons downstream of the injury site degenerate, leaving behind SCs that dedifferentiate to a progenitor-like state and divide inside their basal lamina. The dedifferentiated SCs, together with resident and infiltrating macrophages, clear the axonal and myelin debris, thereby generating a conducive environment for newly formed axons. The SCs then organize themselves into cellular cords that will guide the regrowing axons back to their targets. This period is associated with a robust inflammatory response: inflammatory cells, including mast cells, neutrophils, and T cells, enter the nerve in large numbers, both at the damage site and throughout the length of the distal stump. Following axonal regrowth, SCs redifferentiate in response to axonal signals and the inflammatory response resolves to give rise to a repaired and functional nerve (Fawcett and Keynes, 1990; Scherer and Salzer, 2001; Zochodne, 2008) . It has frequently been observed that neurofibromas resemble the ''injured'' state in that they are composed of a similar complex mixture of cells found in the nerve following injury, and the SCs in the tumor are dedifferentiated and mostly dissociated from axons. Because of this, neurofibromas have been referred to as ''unrepaired wounds'' (Parrinello and Lloyd, 2009; Riccardi, 1992) .
Recent work from our laboratory has shown that strong and sustained activation of the Raf/ERK Ras-downstream pathway in SCs in vivo is sufficient to induce fully differentiated mSCs to revert to a progenitor-like state and dissociate from axons (Napoli et al., 2012; Parrinello et al., 2008) . Moreover, we found that signals from the dedifferentiated SCs orchestrated the inflammatory response via the secretion of cytokines. Therefore, a reasonable model of neurofibroma formation suggested that NF1 loss via elevated Ras/Raf/ERK signaling would be sufficient to drive many of the early stages of tumor formation.
However, recent mouse models have contradicted this simple model. Loss of Nf1 in SCs during development resulted in the formation of normal nerves, although tumors developed in adulthood, whereas loss of Nf1 in adult SCs did not result in frequent tumor formation (Joseph et al., 2008; Le et al., 2011; Wu et al., 2008; Zheng et al., 2008) . These results suggested that in the context of the nerve, Nf1 loss does not affect the ability of SCs to interact with axons or differentiate, and indicated that Nf1 needed to be lost at a specific stage during development to ''prime'' the SC for later tumor development triggered by rare later events (Parrinello and Lloyd, 2009) . Moreover, other cell types also appeared to be important for the development of neurofibromas, as tumors frequently developed only in a Nf1 +/À background, suggesting that other Nf1 +/À cell types are required for tumor formation Zhu et al., 2002) . Here, we analyzed the effect of Nf1 loss in adult mSCs. We found that Nf1 loss was unable to induce ERK activation in adult mSCs, had no effect on the structure of the nerve, and did not result in tumors. However, we found that following injury, Nf1-deficient mSCs formed neurofibromas specifically at the wound site. Interestingly, these tumors formed with a similarly high frequency in both Nf1 +/À and Nf1 +/+ backgrounds. These results show that adult mSCs can be the ''cell of origin'' for neurofibromas. Moreover, they demonstrate that the tumorsuppressive environment of the nerve can be converted to a tumor-promoting environment at a wound site that cooperates with Nf1 À/À SCs to form a neurofibroma. They also identify an alternative mouse model for neurofibroma formation that should be useful for studying the early stages of tumor formation and identifying novel therapeutic strategies.
RESULTS

Targeting Loss of Nf1 in Adult mSCs
To test the effects of Nf1 loss in adult mSCs, we selected a conditional transgenic mouse line expressing the tamoxifen (Tmx)-inducible Cre recombinase (Cre-ERT2) under the control of an SC-specific promoter, P0, which has been shown to be highly specific for mSCs (Leone et al., 2003; Messing et al., 1992 Messing et al., , 1994 . To confirm the specificity of Cre-ERT2 expression and determine the efficiency of recombination, we initially crossed the P0-CreER mice to Rosa26-YFP reporter mice (P0:YFP). The progeny were treated with Tmx for 5 consecutive days and 15 days later, sciatic nerve cryosections were immunostained for yellow fluorescent protein (YFP) and either the mSC marker, P0, or the non-mSC marker, p75. As shown in Figures  1A and 1B, the specificity of recombination appeared to be highly specific for mSCs, as the only detectable YFP+ cells within the sciatic nerve were also P0+. This specificity was confirmed in multiple nerves and sections in which we failed to find a single p75+/YFP+ cell ( Figure 1B ) or a single YFP+/P0À cell, confirming that recombination was not only restricted to SCs but also confined to mSCs. The efficiency of recombination, as determined by counting the percentage of P0+ cells that were positive for YFP, was variable between animals, ranging from a minimum of 15% to a maximum of approximately 50% ( Figure 1C ). Next, P0-CreER mice were mated with Nf1 fl/fl (Zhu et al., 2001) and (Brannan et al., 1994) (Le and Parada, 2007; Zhu et al., 2002) . Two weeks following Tmx treatment, recombination was confirmed by PCR (not shown) and neurofibromin expression was analyzed by western blot, which showed a significant loss of neurofibromin expression in the P0-Nf1 fl/fl and P0-Nf1 fl/À mice ( Figure 1D ).
Loss of Nf1 in Adult mSCs Fails to Activate ERK Signaling or Stimulate Proliferation
To determine the effects of Nf1 loss in adult mSCs, we initially analyzed the sciatic nerves 15 days after the first Tmx injection. We analyzed the number of p75+ cells, which as a marker of dedifferentiated SCs would indicate that SC dedifferentiation had taken place, and performed an analysis of 5-ethynyl-2 0 -deoxyuridine (EdU) incorporation to detect aberrant proliferation ( Figure 1A and S1A). In both cases, we were unable to detect differences between controls and Nf1 mutants, indicating that Nf1 loss does not induce a rapid induction of SC dedifferentiation and/or proliferation (Figures 2A and S1A ). To determine whether Nf1 loss in adult SCs led to changes in the structure of the nerves over the longer term, as was seen in mice in which Nf1 was knocked out in SCs during development, we analyzed the structure of the nerves at 8 months following Nf1 deletion. Analysis of semithin sections of the sciatic nerves showed no detectable differences in the structure of myelinated axons between Nf1 mutants and controls ( Figure 2B ). Moreover, ultrastructural analysis of mutant and control animals revealed normal Remak bundles ( Figure S1B ), which were the first indicators of the initiation of hyperplasia in other NF1 model mice (Wu et al., 2008; Zheng et al., 2008) , and the lack of an inflammatory response ( Figures  S1C and S1D) . Furthermore, no tumors were observed in >60 animals for up to 15 months following the Tmx injections. Consistent with the lack of any phenotype, we could not detect any alteration of ERK activation in Nf1 mutants either by western blot analysis of sciatic nerve lysates ( Figure 2C ) or by immunofluorescence of sciatic nerve sections ( Figure 2D ). Therefore, Nf1 deletion in adult mSCs is not sufficient to activate Ras/ERK signaling or induce a phenotypic or tumorigenic response.
Neurofibromas Develop Specifically at a Wound Site In mice in which Nf1 is knocked out during development, the nerves develop normally. However, as the mice age, the structures of the nerves show abnormalities, with SCs dissociating from axons, and the mice eventually develop tumors, indicating that additional, possibly environmental, signals are involved (Wu et al., 2008; Zheng et al., 2008) . We decided to test whether wounding of the sciatic nerve might cooperate with loss of Nf1 to induce tumorigenesis, as we reasoned that (1) it would cause activation of ERK signaling and dedifferentiation of all SCs distal to the wound, which might provide a pool of proliferating Nf1
SCs from which a tumor could develop; and (2) it would trigger a potent inflammatory response along the length of the nerve and might thus provide a protumorigenic environment. We therefore performed partial transections of the right sciatic nerve 15 days following Tmx treatment in both P0-Nf1 fl/fl and P0-Nf1 fl/À mice and the corresponding Nf1 fl/fl and Nf1 fl/À controls. Six to 8 months following injury, the animals were sacrificed and analyzed for changes to the structure of the nerves and tumor formation ( Figure 3A ). Upon gross dissection, similar high proportions of both P0-Nf1 fl/fl and P0-Nf1 fl/À mice exhibited visible tumors at the injury site (33.3% and 34.6%, respectively), indicating that Nf1 loss in mSCs is able to cooperate with a wounding response to induce tumor formation. These results also showed that the Nf1 genetic background did not contribute to the rate of tumor formation in this mouse model (Figures 3B and 3C) . In contrast, the control animals displayed apparently well-regenerated sciatic nerves. A single exception was one Nf1 fl/À mouse, which had a microscopically enlarged nerve.
Given the rarity of this event and the fact that it occurred in a heterozygous background, it is tempting to speculate that this tumor may have resulted from loss of heterozygosity at the Nf1 locus. The unwounded contralateral nerves of the Nf1 mutants were also unaffected in that they were indistinguishable from uncut controls, arguing against a possible systemic contribution to tumor formation. The structure and composition of the tumors that developed in Nf1-deficient mice were characterized and compared with the equivalent region of control animals at 8 months following injury. Cross-sections of the nerve showed a remarkable enlargement of the peripheral nerves in Nf1-deficient mice compared with controls ( Figures 3C and S2A ), with Hoechst staining showing an increase in cell density in the mutant nerves ( Figure S2B ). Histological examination of the sciatic nerves by our pathologist revealed that the tumors that developed in the mutant mice could be classified as GEM grade I neurofibromas (StemmerRachamimov et al., 2004) . Hematoxylin and eosin (H&E) staining showed that the tumors were composed of increased numbers of disorganized spindle-shaped cells, infiltrating mast cells, and other inflammatory cells in a collagen-rich matrix, and resembled neurofibromas seen in other GEM models of neurofibroma formation ( Figure 3D ; Cichowski et al., 1999; Le et al., 2011; Wu et al., 2008; Zheng et al., 2008) . Moreover, the tumors were also positive for S100, although the levels were lower than those found within the uninjured part of the nerve ( Figures S2C  and S2D ). Early examination of nerves at 3 months showed that the mutant nerves had small tumors that continued to grow and eventually gave rise to the larger tumors seen at 6-8 months. In addition, a proportion of these tumors ($10%) progressed along the distal stump of the nerve, consistent with the neoplastic nature of these tumors ( Figure S2E ). EdU-labeling experiments showed increased proliferation rates within the tumor regions compared with those seen in regenerated control nerves, and some of these proliferating cells were SCs ( Figures  S3A-S3C ). Structural analysis of semithin and ultrathin sections confirmed the differences in structure between the regenerated control nerves and the tumors that formed in the Nf1 mutant mice. Repaired sciatic nerves from control mice were tightly packed with myelinating axons, with little intervening space, and electron microscopy (EM) analysis showed well-organized minifascicles, which form as part of the regeneration process ( Figure S3D ). There were also no discernible repair abnormalities in the Nf1 +/À mice, which although previously reported to exhibit skin wound-repair defects (Atit et al., 1999) , appeared able to repair nerves normally. In contrast, the tumors in the Nf1 mutants resembled neurofibromas seen in other mouse models (Cichowski et al., 1999; Wu et al., 2008) . They had a highly disorganized structure with a significantly expanded interstitial compartment with increased cellularity between myelinated axons. EM analysis revealed numerous denervated SCs, fibroblasts, ''perineurial-like'' cells, mast cells, and the occasional ''naked'' axon in a dense collagen matrix ( Figures 3E, 3F , and S3D). Consistent with the mixed-cell See also Figure S1 .
composition of these tumors, immunostaining showed a large increase in the numbers of mast cells, macrophages, neutrophils, and T cells within the tumors compared with the regenerated regions of the control nerves, and activated fibroblasts were found in the tumors but never in the regenerated nerves ( Figure S4 ). YFP+ and most appeared to be dissociated from axons ( Figure 4A ). Moreover, the YFP+ cells expressed p75, a marker of dedifferentiated/non-mSCs ( Figure 4B ), thus clearly demonstrating that loss of Nf1 in mSCs in the context of a wound results in the maintenance of these cells in their ''progenitor-like' state, dissociation from axons, and abnormal proliferation. Indeed, in some tumors, this abnormal behavior included invasion of YFP+ cells into adjacent muscle ( Figure 4A) .
Nf1-Deficient
The ability to ''mark'' the cells derived from recombined mSCs enabled us to make several observations concerning the ''neoplastic'' cells within the tumors with relevance to the pathology of the tumors. The first observation was that, although expression of the SC marker S100 is commonly used as a diagnostic criterion of neurofibromas, we found that the YFP+ cells within the tumor were mostly negative for S100. Instead, S100 expression was mostly restricted to intact mSCs, both scattered throughout the tumor and associated with the unwounded regions ( Figure 4C ). These results were consistent with the low levels of S100 staining seen in paraffin-embedded tumors, which showed low levels of S100+ cells within the tumor but high levels within the undamaged part of the nerve ( Figure S2C ).
The second observation was that some of the YFP+ cells within the tumor exhibited the morphology traditionally attributed to ''perineurial-like'' cells, which commonly make up a high proportion of neurofibromas (Figures 4B and S5B; Erlandson, 1985) . These extremely thin cells exhibit long cytoplasmic processes enwrapping other cells and could be seen in all the tumors, albeit at varying frequency both between and within the tumors (compare the upper and lower panels of Figure 4A ), which is consistent with a study of human neurofibromas (Lassmann et al., 1976) . A comparison of immunofluorescence images and EM micrographs revealed a striking resemblance between many of the YFP/p75-expressing cells and cells that are frequently found in EM images of neurofibromas and traditionally are identified as ''perineurial-like'' (Figures S5A and S5B; Erlandson, 1991) . Moreover, ultrastructural analysis showed that these cells contained multiple pinocytic vesicles and a partial basement membrane that is characteristic of these cells ( Figures 4D  and S5A ). This suggests that despite their distinct ultrastructural morphology, many of these cells are derived from mSCs and contribute to the neoplastic potential of the tumor. To characterize these cells further, we used two markers of perineurial cells, Glut1 and epithelial membrane antigen (EMA). In control nerves, we were able to show that Glut1 specifically stained the perineurial cells and the blood vessels ( Figure S5B) ; however, consistent with other studies, we could not detect any EMA+ cells within the mouse nerve (Takebe et al., 2008) . In contrast, within the tumors we detected multiple Glut1+ cells. Consistent with the observation that some of the YFP+ cells resembled perineurial cells, a proportion of the YFP+ cells with a perineurial-like morphology were positive for Glut1 (Figure S4D) . However, only a proportion of these perineurial-like cells were YFP+, which suggests that ''normal'' perineurial cells, or possibly pericytes, are also behaving abnormally and make up a significant component of the tumor. Finally, we were able to identify rare YFP+ cells that were negative for both S100 and p75 markers, suggesting that neurofibromas may contain rare cell populations derived from P0+ mSCs that have lost their original identity ( Figure S5B ). In contrast to the homogeneous distribution of YFP+ cells in neurofibromas, only a few positive cells were found at the injury site in controls ( Figure S5E ).
Distal to the Wound Site, Nf1-Deficient SCs Remyelinate Normally An important observation was that tumors only develop at the wound site. After nerve injury, strong Ras-Raf-ERK activation followed by dedifferentiation and proliferation is seen in all SCs at the wound site and throughout the entire distal stump. Moreover, there is a robust inflammatory response throughout the length of the distal stump. To determine the structure of the regenerated nerves in the control and mutant nerves, we performed a structural analysis, which showed that distal to the injury, control and mutant mice nerves regenerated to a similar extent and were indistinguishable ( Figures 5A and 5B) . These results indicated that, in contrast to the wound site, in the environment of the distal nerve stump, Nf1 À/À SCs appeared to behave normally. However, as we only achieved a maximum of 50% recombination, a separate possibility was that Nf1 À/À SCs failed to reassociate with the regenerating axons and as a result died or were otherwise lost from the nerve. To exclude this possibility, we examined the fate of Nf1 À/À SCs (YFP+) in the distal region of mutant mice in which tumors had developed at the wound site. In sharp contrast to what we encountered at the tumor site, we found that nearly all YFP+ cells were associated with axons and expressed S100 ( Figures 5C and 5D ). Many were myelinating, indicating they had returned to their original fate; however, the occasional YFP+ cell was found to be p75+ and associated with axons, suggesting that Nf1 À/À mSCs were capable of differentiating to the nonmyelinating cell type following an injury. These results demonstrate that an identical genetic insult to a specific target cell can have distinct outcomes depending on the microenvironmental context. In the distal stump of the nerve, the environment is tumor suppressive, with dedifferentiated SCs reassociating with regrowing axons and undergoing redifferentiation. In contrast, at the wound site the environment is tumor promoting. However, consistent with a role for the ERK signaling pathway in maintaining the dedifferentiated state and driving SC proliferation, sustained elevated levels of ERK signaling were detected specifically at the wound site in the Nf1 mutant animals. Western blot analysis showed that in contrast to control animals, in which P-ERK levels returned to low levels by day 5 after injury, the P-ERK levels remained high in the mutant nerves ( Figure 6A ). Moreover, immunostaining showed that the elevated signaling was confined to the injury site from which the tumor developed, and was associated with increased proliferation of Nf1 À/À cells specifically at the wound site ( Figures 6B and 6C ).
DISCUSSION
Identifying the ''cell of origin'' from which tumors can or do derive has been the aim of many recent animal models of cancer. The results have been diverse, with cancers shown to be capable of arising from stem cell and progenitor populations but also sometimes from fully differentiated cell types (Visvader, 2011) . In NF1-associated neurofibromas, the picture is similarly complex. A series of mouse models in which Nf1 was specifically deleted from the SC lineage at various developmental stages indicated that for tumors to occur, Nf1 had to be lost during a specific developmental window at approximately embryonic day 13 (Joseph et al., 2008; Wu et al., 2008; Zheng et al., 2008) . However, the tumors only developed later in adulthood and appeared to derive from the nonmyelinating population. In contrast, in a separate study, transplant experiments suggested that dermal neurofibromas could derive from neural-crest-like stem cells termed skin-derived precursors (SKPs) (Le et al., 2009) . In this study, we used a highly specific promoter to delete Nf1 from mSCs in adult mice to determine whether these highly specialized, quiescent cells can give rise to neurofibromas. We found that, alone, loss of Nf1 in mSCs had no effect on nerve structure and did not result in tumor formation. However, neurofibromas formed with high efficiency following damage to the Nf1-depleted nerve. Although these results do not address whether tumors can derive from adult non-mSCs, they clearly demonstrate that adult mSCs can be the ''cell of origin'' for neurofibromas, and that cooperating microenvironmental signals found only at the wound site are essential for tumors to form. The finding that tumors only develop at the wound site has several important implications. Following a nerve injury, mSCs dedifferentiate along the length of the nerve in response to a sustained signal through the ERK signaling pathway and there is a ) mice at the indicated time points after injury. Note that the ERK signal is sustained at day 7 in mutant mice (blot representative of four different animals for each genotype). (B) Seven days after injury, cryosections of sciatic nerves were immunolabeled for the mSC marker P0 (green) and p-ERK (red). Nuclei were counterstained with DAPI. Upper panel: site of injury; bottom panel: distal region. ERK pathway activation is sustained only at the site of injury in Nf1 mutants (representative images of three animals analyzed for each group). (C) EdU incorporation was assessed 7 days after injury in control and mutant mice at the site of injury (left) and distal to the injury site (right). Results show the means of EdU+/YFP+ cells ± SEM (n = 3 of each group); *p < 0.05. robust inflammatory response along the length of the nerve. The fact that tumors only form at the injury site shows that robust activation of ERK signaling, dedifferentiation and proliferation of SCs, and an inflammatory response is not sufficient to trigger tumor formation but that tumor formation also requires the specific microenvironment of the wound site. While an important question that remains to be resolved involves the nature of these cooperating signals at the wound site, an equally important question is, why do Nf1 À/À SCs behave normally within the distal stump of the nerve, acting as wildtype cells to remyelinate the regrown axons? The ''tumor-suppressive'' environment of the nerve is further indicated by the earlier studies in which Nf1 was deleted from SCs during embryogenesis. In these studies, the Nf1 À/À SCs behaved more or less normally to form both Remak Bundles and myelinated axons (Wu et al., 2008; Zheng et al., 2008) . It was only during adulthood that slight defects in the Remak bundles could be observed, and it was suggested that tumors derived from these destabilized structures. Although these studies suggested that tumors derive from adult non-mSCs, their models are somewhat similar to ours in that the destabilization of the Remak bundles resembles aspects of the injured state artificially induced in our model. Consistent with this idea, tumor formation was associated with an early inflammatory response. It is possible that tumors developed from the nonmyelinating population because loss of Nf1 at that specific developmental stage specifically affected the stability of Remak bundles, and that tumors could also develop from mSCs in these mice if they were injured. The finding that loss of Nf1 in adult SCs does not result in efficient tumor formation is also consistent with a separate study in which Nf1 was deleted in adult SCs and tumors only arose in rare cases in older animals (Le et al., 2011) . It is not an unlikely scenario that tumors arose in these animals following a naturally occurring traumatic injury.
The tumor-suppressive environment of the nerve is further highlighted by observations that in vitro, Nf1 loss in SCs is sufficient to induce a Ras-like phenotype and elevated Ras/Raf/ERK signaling that inhibits SC-axonal interactions and blocks SC differentiation, indicating that neurofibromin is a limiting GAP in the in vitro environment (Napoli et al., 2012; Parrinello et al., 2008) . This must mean that within the nerve, either neurofibromin is not a limiting GAP or the environment can act to suppress the ERK signaling pathway. Moreover, it might also suggest that the tumor-promoting wound environment mimics the in vitro environment, which is consistent with the view that in vitro culture reflects an in vivo wounded response (Iyer et al., 1999) . It will be crucial to dissect the mechanisms involved, as identification of both tumorsuppressive and tumor-promoting signals will lead to useful therapeutic targets that could potentially prevent the development of tumors both during development and in adulthood.
A link between wounding and tumorigenesis has long been recognized (Balkwill and Mantovani, 2001; Martins-Green et al., 1994) . Recent mouse models in the pancreas and skin have shown that an injured or chronically inflamed environment is a critical cooperating event with specific genetic changes in order for tumors to occur, and these models have parallels to human diseases in which chronic tissue damage can precede tumor formation (Arwert et al., 2012; Guerra et al., 2007; Kasper et al., 2011; Wong and Reiter, 2011) . Importantly, there is a longstanding clinical hypothesis that neurofibroma formation is fostered by local trauma and injury, and hence neurofibromas are often referred to as unrepaired wounds. Our results are consistent with this hypothesis and indeed suggest that a neurofibroma could be considered as an ''exaggerated or neoplastic neuroma''-an unrepaired ''wound'' of the peripheral nerve (Lassmann et al., 1976; Riccardi, 1992 Riccardi, , 2007 . Because NF1 patients are born heterozygous for NF1, with the loss of the second allele, a bottleneck event for neurofibroma formation, injury is likely to increase the frequency of this event by inducing SC proliferation. Importantly, however, our results indicate that injury may play an additional role by creating a protumorigenic microenvironment required by NF1-deficient cells to induce tumorigenesis. To determine whether this is the case, it will be important to define the nature of the protumorigenic environment, establish whether it is induced by the more common types of human nerve injuries (e.g., crush injuries), and determine a link to tumorigenesis in patients with such injuries.
A fascinating observation in a previous model of NF1 is that tumors only develop in a Nf1 +/À background, implicating other Nf1 +/À cell types, in particular mast cells, in neurofibroma formation Zhu et al., 2002) . In contrast, we found that the Nf1 background had no effect on the rate of tumor formation, given that tumors formed with similar efficiencies in both Nf1 for the SC marker S100, which is commonly used to diagnose these tumors. Instead, the S100+ cells within the tumor were mostly YFPÀ and appeared to be the result of normal SCs within the tumors, as they appeared to be interacting mostly with axons. This is reminiscent of previous observations made by Cichowski et al. (1999) in neurofibromas in a Nf1 +/À ;Nf1
chimeric mouse model, and may be consistent with the often low levels of S100 seen in human tumors (Hirose et al., 2003; Tucker et al., 2011) . Importantly, the analysis of YFP+/S100À/ p75+ cells also revealed that a number of these mSC-derived cells appeared to be morphologically distinct from SCs. Instead, they exhibited a characteristic morphology (a long cytoplasmic process displayed in arrays or enwrapping other cells) associated with ''perineurial-like'' cells, which are a frequent cellular component of neurofibromas and are often considered to be of fibroblast origin. However, it was previously speculated based on ultrastructural studies that these cells could derive from SCs, as frequent ''transitional'' cells with shared SC/perineurial features were observed (Erlandson, 1991) . Our results indicate that some of these cells most likely originate from NF1 À/À SCs and are likely to be key drivers of the tumor. In summary, our results demonstrate that neurofibromas can originate from adult mSCs following loss of Nf1. However, tumor formation requires a protumorigenic environment that can be provided by signals specifically found at the site of a nerve injury. In contrast, these results indicate that, normal nerves constitute a tumor-suppressive environment. This mouse model gave us the opportunity to track the fate of Nf1 À/À -induced mSCs, which led to the important observation that these cells give rise to both S100À tumor cells and tumor cells with a ''perineurial-like'' morphology. In future studies, investigators will be able to track the initial development of these tumors and identify mechanisms by which environmental signals can contribute to tumor formation.
EXPERIMENTAL PROCEDURES
Mouse Strains Nf1 flox/flox (Zhu et al., 2001) and Nf1 floxl/À (Jacks et al., 1994 ) on a mixed 129/ Bl/6 background were crossed with P0CreERT2 C57Bl/6 mice (Leone et al., 2003) mice were bred to LacZRosa (Soriano, 1999) and to YFPRosa (Soriano, 1999) .
Tmx Treatment and Nerve Partial Transections
Tmx (Sigma) was dissolved in sunflower oil at 20 mg/ml and filtered through a 0.2 mm filter. Control and Nf1 mutant mice (5-6 weeks old) received intraperitoneal injections of 2 mg of Tmx once a day for 5 consecutive days. Fifteen days after the first Tmx injection, the mice were anesthetized with isoflurane and the right sciatic nerve was exposed at the sciatic notch. The nerve was half-transected using scissors, so that the perineurium was breeched and approximately half of the axons were severed within each nerve. The wound was then closed with clips. The entire nerve and the unwounded contralateral were recovered at the indicated time points following surgery. Nerves were immediately fixed in 4% paraformaldehyde for immunohistochemistry or frozen in liquid nitrogen for protein analysis.
Cell Proliferation Assay
Cell proliferation was measured by EdU incorporation (Invitrogen). Mice were pulsed with 1 mg of EdU at 5 hr before sacrifice. The sciatic nerves were dissected and processed for immunofluorescence. Nerve sections were then stained using the Click-iT EdU cell proliferation assay kit (Invitrogen) according to the manufacturer's instructions.
Statistical Analysis
The data are represented as mean values ± SEM. One-way ANOVA with Bonferroni post hoc test was used for statistical analysis, and p values considered significant were indicated by asterisks as follows: *p < 0.05, **p < 0.01, and ***p < 0.001. For further details regarding the materials and methods used in this work, please see the Extended Experimental Procedures.
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